EL vs GYRE · rev $15.05B vs rev $53.5M
Estee Lauder Companies Inc (EL) versus Gyre Therapeutics Inc. (GYRE) — a side-by-side from cached financials, not a winner call.
Estee Lauder Companies Inc (EL) is a household & personal products company listed on US.
Gyre Therapeutics Inc. (GYRE) is a biotechnology company listed on NASDAQ.
Latest reported EL revenue for 2026-06-30 was $15.05B. Net income was $182.0M. Revenue was up 5.0% from 2025-06-30 to 2026-06-30. EL currently screens at market cap $31.92B.
Latest reported GYRE revenue for 2026-06-30 was $53.5M. Net income was -$32.8M. GYRE currently screens at market cap $589.9M.
EL currently screens at market cap $31.92B. GYRE currently screens at market cap $589.9M.
Not investment advice. Open the EL and GYRE stock pages for the full models.
Not investment advice.